For a lot of patients who arrive at our clinic for kratom or 7-OH dependence, mental health is already in the picture — often it’s a reason they started using in the first place. The Tennessee Department of Health’s 2026 kratom surveillance data captures this formally: 18.1% of kratom-related ER visits in Tennessee (2019–2025, n=414) involved a mental health event — anxiety, panic, insomnia, hallucinations, or altered mental status either triggered or worsened by kratom use.
This article is about the two-way relationship: how mental health pushes people toward kratom, and how kratom use and withdrawal pull mental health further down.
Why People With Anxiety or Depression Reach for Kratom
Kratom marketing often promises energy, focus, mood elevation, or stress relief — which maps onto exactly what patients with untreated or poorly-treated anxiety and depression are reaching for. SAMHSA’s 2021–2023 NSDUH data shows past-year kratom use exceeds 2% in adults with serious psychological distress or major depressive episode — meaningfully higher than the general-population rate of 0.68%. People with co-occurring substance use or prescription misuse show prevalence above 5%.
In plainer terms: kratom is over-represented in populations trying to self-medicate. This isn’t a moral judgment; it’s a pattern that shows up consistently in large-scale survey data. The pattern usually starts gently — someone tries kratom at a friend’s suggestion or after reading about it, notices their anxiety feels lower or their mood feels slightly better, and begins using more regularly.
What happens next is predictable pharmacologically. Kratom activates the mu-opioid receptor, which produces short-term anxiolytic (anxiety-reducing) effects for many users — but the brain adapts to that input. Over weeks to months, the baseline anxiety creeps back up between doses, often worse than before, and doses stack through the day to keep it down. This is the self-medication trap: the thing providing short-term relief is causing the condition it’s treating to get worse in the medium term.
What Withdrawal Does to Mental Health
If you have any underlying anxiety, depression, trauma history, or mood disorder, kratom withdrawal amplifies it. Not gently. Patients consistently describe the first week of unsupported kratom withdrawal as producing:
- Severe anxiety, often crossing into panic. Physiological autonomic activation (sweating, fast heart rate, restless legs) drives cognitive anxiety even if there’s no specific trigger.
- Deep low mood, sometimes meeting clinical criteria for a depressive episode. The word patients most often use is “gray.”
- Insomnia that worsens both anxiety and depression.
- Intrusive thoughts, sometimes suicidal ideation. This is the clinical risk point. If you have any history of suicidality and you’re considering unsupported kratom withdrawal, get medical support first.
- Emotional lability — crying jags, irritability, sudden anger — particularly for patients with trauma histories.
The TN ED data reflects this in aggregate. Of the kratom ER visits classified as mental health events (18.1% of 414 visits, 2019–2025), anxiety, panic, and insomnia were the most-reported presentations, along with altered mental status and hallucinations in a smaller share. Symptom patterns during withdrawal are not uniform — they follow the underlying mental health landscape.
The Post-Acute Window
Physical kratom withdrawal typically resolves in 5–10 days. The mental health piece often doesn’t.
A lot of patients describe weeks or occasionally months of flat mood, low motivation, and intermittent anxiety after the physical symptoms fade. Clinically this is post-acute withdrawal syndrome (PAWS), and it’s the stage where most unsupported relapses happen — not because the patient lacks willpower, but because life feels gray and the substance that used to color it is available at a smoke shop down the street.
Two things are worth knowing about PAWS:
- It improves over time as your brain chemistry rebalances. Months, not years, for most patients.
- It’s much less pronounced on MAT. Buprenorphine stabilizes receptor activity so the “gray” window is compressed or largely avoided. Patients on MAT don’t tend to describe PAWS the way unsupported-withdrawal patients do.
Why Integrated Care Works Better
For decades the dominant treatment model in addiction medicine was sequential: detox first, mental health second, or vice versa. The evidence base has shifted hard away from that. For patients with co-occurring substance use and mental health conditions (which is most patients), integrated treatment — one team handling both at the same time — produces better outcomes than sequential referrals.
Our clinic is designed for this. A first visit for kratom dependence with co-occurring anxiety or depression looks like:
- Intake covers both substance use history and mental health history. The DSM-5 assessment includes both categories.
- Counseling is with clinicians who work across substance use and mental health. You don’t have to explain the kratom part to one person and the anxiety part to another.
- Medical provider evaluation covers both MAT prescribing and psychiatric medication management, if appropriate. An SSRI, SNRI, or other psychiatric medication can be started alongside buprenorphine when indicated.
- Ongoing care is coordinated. The provider prescribing your buprenorphine also has visibility into the psychiatric medication decisions, and vice versa.
For a broader picture of our integrated approach, see the behavioral health section of our services page.
What “Treatment” Actually Looks Like for This Combination
For a kratom-dependent patient with co-occurring anxiety or depression, a typical treatment plan might include:
- Buprenorphine-based MAT (Suboxone, or Sublocade/Brixadi injection). Quiets cravings, prevents withdrawal, stabilizes the receptor system that anxiety was riding on.
- Psychiatric medication management where appropriate. SSRIs or SNRIs for anxiety and depression; bupropion or mirtazapine in specific situations; trauma-focused pharmacotherapy if relevant. Medication decisions are individualized.
- Individual counseling with a therapist experienced in co-occurring care. Cognitive-behavioral approaches, motivational interviewing, and trauma-informed care depending on your needs.
- Peer support from specialists with lived-experience recovery from similar patterns.
- Group IOP (Intensive Outpatient Programming) for patients who benefit from structured group care alongside individual treatment.
Not every patient needs every element. Your first visit determines what fits your situation.
What Not to Do
- Don’t stop psychiatric medication abruptly to “get clean” before coming in. Stopping SSRIs or similar medications suddenly causes its own problems and can destabilize your mental health during an already rough window.
- Don’t stop kratom cold turkey if you have untreated anxiety, depression, or trauma. The amplification during withdrawal is real and is a common reason for relapse.
- Don’t wait for the mental health side to be “fixed” before seeking kratom treatment. They’re intertwined. Treating them together works better than trying to separate them.
If You’re Ready to Talk
Call 423-498-2000 or submit a contact request. Tell our intake team about both the kratom use and the mental health picture. Same-week appointments are available at all four clinic locations. Our team is set up for exactly this kind of integrated intake.
If you’re currently experiencing suicidal thoughts, please call 988 (the Suicide and Crisis Lifeline) immediately.